Roche to Acquire Telavant Holdings in $7.1 Billion Deal
Swiss healthcare company Roche has announced its plans to acquire Telavant Holdings in a $7.1 billion transaction.
Source: echemi.com
Page 40 - Roivant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roivant Sciences Today - Breaking & Trending Today
Sumitomo Pharma : Strategy -October 23, 2023 at 02:01 am EDT
1897 Dainippon Pharmaceutical 1944 ...
Source: marketscreener.com
Sumitomo Pharma : Business -October 23, 2023 at 02:03 am EDT
1897 Dainippon Pharmaceutical 1944 ...
Source: marketscreener.com
:max_bytes(150000):strip_icc()/GettyImages-1437342966-5ce4abea9fb746179333980018b0056e.jpg)
5 Things to Know Before Markets Open
Chevron announced it will buy Hess for $53 billion and Apple shares fell after China launched tax probes into key supplier Foxconn. Here’s what investors need to know today.
Source: investopedia.com
Roche to buy autoimmune drugmaker from Pfizer, Roivant for $7B
Roche has agreed to acquire Telavant Holdings, maker of an inflammatory bowel disease drug, from Roivant Sciences and Pfizer for $7.25 billion.
Source: beckershospitalreview.com